[Levallois-Perret, France — November 14, 2025] — Linxens, a global leader in component-based solutions, and Presto Engineering, a leading provider of advanced ASIC design and production services, today announced a strategic collaboration on a next-generation platform of connected biosensors. The initiative will be showcased at MEDICA 2025, the world’s largest medical trade fair, where Presto Engineering and Linxens will share the first results of this collaboration.
A biosensor platform concept for the next era of diagnostics
The collaboration lays the foundation for a scalable platform that integrates sensing, connectivity, and semiconductor intelligence into a single disposable device. By combining Presto’s next-generation ASIC (application-specific integrated circuit) capabilities with Linxens’ expertise in flexible biosensor transducers, electrodes, antennas, and high-volume industrial manufacturing, the companies are working toward a biosensor platform that is powerful, cost-efficient, and adaptable across diverse applications.
The platform is designed around four guiding principles:
Broad potential across healthcare and beyond
Designed as a flexible, modular platform, the solution supports a wide range of use cases – from faster, contamination-free point-of-care testing and discreet wearable monitoring to rapid on-site analysis in food safety and environmental control. Its architecture enables quick adaptation to emerging diagnostic needs while preserving scalability and cost efficiency. By framing their initiative as a platform concept, Linxens Healthcare – Linxens’ dedicated health brand – and Presto Engineering aim to deliver faster workflows, enhanced portability for field or low-resource settings, and more comfortable, discreet monitoring devices that can improve patient adherence. In industrial and environmental contexts, it supports on-site testing of pathogens or contaminants, helping to ensure safety and deliver fast, digital results in process-critical environments.
Leadership perspectives
“This collaboration is about more than just a new concept — it’s about laying the foundation for a platform that makes connected diagnostics practical, affordable, and scalable for real-world healthcare,” said Pierre O. Beal, Healthcare Product Strategy Manager at Linxens Healthcare. “We see this as a basis for future innovation in testing and monitoring, empowering providers and patients with reliable digital data at the point of need.”
“From a technology standpoint, the breakthrough lies in embedding intelligence directly into the biosensor platform,” explained Frédéric Valentin, SVP Sales & Marketing at Presto Engineering. “Our next-generation silicon platform brings secure connectivity and advanced signal processing into a compact, disposable format. When combined with Linxens’ flexible electronics and industrial-scale manufacturing, it creates a versatile architecture that can be tailored to applications ranging from infectious disease testing to wearable patient monitoring.”
About Linxens
Linxens Group, global leader in electronic component-based solutions for connectivity, traceability, and authentication, has over 40 years of industrial excellence. Linxens Healthcare is a brand of the Linxens Group, focused on delivering advanced solutions for the healthcare sector. Leveraging the Group’s expertise in micro-connectors and flexible electronics, Linxens Healthcare designs and manufactures biosensors, electronic skin patches and wearables, and solutions in Track & Trace that enable precise monitoring, diagnostics, and patient care. operates 7 R&D centers and 8 factories worldwide, employing more than 3,000 people worldwide.
About Presto Engineering
Presto Engineering is a leading provider of Application-Specific Integrated Circuits (ASICs) for advanced medical devices, including wearables and diagnostics, with ISO 13485 certification. With over 35 years of circuit design and production expertise, Presto manages the entire process in-house, from feasibility to volume manufacturing. Presto’s custom ASICs enable miniaturization, low power consumption, IP protection, and long-term reliability, ensuring device safety and performance. The company has also developed customizable silicon platforms for medical, offering validated, taped-out IC foundations that reduce risk and accelerate time-to-market. Headquartered in France, with two European labs and operations in North America and Asia, Presto combines global reach with local expertise to support next-generation medical innovation.
Press contact for Linxens :
the messengers
Alicja Prodhomme/Hannah Grunbaum/Pauline Moreau
Press Contact for Presto Engineering:
Sandy Fewkes
+1 408 529 9685
SandyLFewkes@gmail.com
